Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chronic pain
Biotech
Latigo raises $135M to catch up to Vertex in chronic pain
Latigo is emerging out of stealth with $135 million and a clinical-stage pain candidate currently being tested in healthy volunteers.
Max Bayer
Feb 14, 2024 5:00am
FDA expands OK for Boston Sci WaveWriter spinal cord stimulators
Feb 6, 2024 12:28pm
Miniature neurostimulator developer Nalu Medical nets $65M
Jan 4, 2024 11:16am
Digital therapeutics maker BehaVR merges with Fern Health
Nov 16, 2023 1:00pm
Drug more effective on pain than gabapentin, minus side effects
Nov 14, 2023 10:00am
Medtronic's self-adjusting spinal cord stimulator snags CE mark
Aug 28, 2023 11:30am